Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04000282
Title First-in-human Single Agent Study of SAR442085 in Relapsed or Refractory Multiple Myeloma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sanofi
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GRC | FRA | ESP | CZE

Facility Status City State Zip Country Details
City of Hope Site Number : 8400002 Duarte California 91010 United States Details
Dana Farber Cancer Institute Site Number : 8400003 Boston Massachusetts 02115 United States Details
Mayo Clinic of Rochester Site Number : 8400005 Rochester Minnesota 55905 United States Details
UNC Chapel Hill Site Number : 8400006 Chapel Hill North Carolina 27599 United States Details
Froedtert Hospital & Medical College of Wisconsin Site Number : 8400004 Milwaukee Wisconsin 53226 United States Details
Investigational Site Number : 2030002 Brno 62500 Czechia Details
Investigational Site Number : 2030003 Ostrava - Poruba 70852 Czechia Details
Investigational Site Number : 2030001 Praha 2 12808 Czechia Details
Investigational Site Number : 2500001 TOULOUSE Cedex 9 31059 France Details
Investigational Site Number : 3000001 Athens 11528 Greece Details
Investigational Site Number : 7240001 Salamanca 37007 Spain Details
Investigational Site Number : 1580001 Taipei 10002 Taiwan Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field